Novel glycosylation of HLA-DRα disrupts antigen presentation without altering endosomal localization

Journal of Immunology

Volumn 160, Issue 9, 1998, Pages 4289-4297

  Guerra, Carolyn B ^a   Busch, Robert ^b   Doebele, Robert C ^a,b   Liu, Wendy ^b   Sawada, Tetsuji ^c   Kwok, William W ^d   Chang, Ming Der Y ^c   Mellins, Elizabeth D ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^d BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; HLA DR ANTIGEN;

ANTIGEN PRESENTATION; ARTICLE; CELL FRACTIONATION; ENDOPLASMIC RETICULUM; ENDOSOME; GLYCOSYLATION; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MUTATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ANTIGEN PRESENTATION; B-LYMPHOCYTES; BIOLOGICAL TRANSPORT; CELL LINE; ENDOSOMES; GLYCOSYLATION; HLA-DR ANTIGENS; HUMANS; MUTATION;

EID: 0032080436     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Anderson, M. S., and J. Miller. 1992. Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA 89:2282.
2. Bonnerot, C., M. S. Marks, P. Cosson, E. J. Robertson, E. K. Bikoff, R. N. Germain, and J. S. Bonifacino. 1994. Association with BiP and aggregation of class II MHC molecules synthesized in the absence of invariant chain. EMBO J. 13:934.
3. Roche, P. A., and P. Cresswell. 1990. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature 345:615.
4. Busch, R., I. Cloutier, R.-P. Sékaly, and G. J. Hämmerling. 1996. Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum. EMBO J. 15:418.
5. Anderson, K. S., and P. Cresswell. 1994. A role for calnexin (IP90) in the assembly of class II MHC molecules. EMBO J. 13:675.
6. Kleijmeer, M. J., S. Morkowski, J. M. Griffith, A. Y. Rudensky, and H. J. Geuze. 1997. Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments. J. Cell Biol. 139:639.
7. Morton, P. A., M. L. Sacheis, K. S. Giacoletto, J. A. Manning, and B. D. Schwartz. 1995. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peplide binding in B-lymphoblastoid cells. J. Immunol. 154:137.
8. Peters, P. J., G. Raposo, J. J. Neefjes, V. Oorschot, R. L. Leijendekker, H. J. Geuze, and H. L. Ploegh. 1995. Major histocompatihility complex class II compartments in human B lymphoblastoid cells are distinct from early endosomes. J. Exp. Med. 182:325.
9. West, M. A., J. M. Lucocq, and C. Watts. 1994. Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells. Nature 369:147.
10. Ghosh, P., M. Amaya, E. Mellins, and D. C. Wiley. 1995. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378:457.
11. Morris, P., J. Shaman, M. Attaya, M. Amaya, S. Goodman, C. Bergman, J. J. Monaco, and E. D. Mellins. 1994. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 368:551.
12. Fling, S. P., B. Arp, and D. Pious. 1994. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 368:554.
13. Sloan, V. S., P. Cameron, G. Porter, M. Gammon, M. Amaya, E. D. Mellins, and D.M. Zaller. 1995. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375:802.
14. Denzin, L. K., and P. Cresswell. 1995. HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 82:155.
15. Sherman, M. A., D. A. Weber, and P. E. Jensen. 1995. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 3:197.
16. Weber, D. A., B. D. Evavold, and P E. Jensen. 1996. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 174:618.
17. Kropshofer, H., A. B. Vogt, G. Moldenhauer, J. Hammer, J. S. Blum, and G. J. Hämmerling. 1996. Editing of the HLA-DR-peptide repertoire by HLA-DM. EMBO J. 15:6144.
18. Denzin, L. K., C. Hammond, and P. Cresswell. 1996. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. Med. 184:2153.
19. Kropshofer, H., S. O. Arndt, G. Moldenhauer, G. J. Hämmerling, and A. B. Vogt. 1997. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunin 6:293.
20. Mellins, E. D., P. Cameron, M. Amaya, S. Goodman, D. Pious, L. Smith, and B. Arp. 1994. A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides. J. Exp. Med. 179:541.
21. Sadegh-Nasseri, S., and R. N. Germain. 1991. A role for peptide in determining MHC class II structure. Nature 353:167.
22. Germain, R. N., and L. R. Hendrix. 1991. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353:134.
23. Monji, T., A. L. McCormack, J. R. Yates, and D. Pious. 1994. Invariant-cognate peptide exchange restores class II dimer stability in HLA-DM mutants. J. Immunol. 153:4468.
24. Sanderson, F., C. Thomas, J. J. Neefjes, and J. Trowsdale. 1996. Association between HLA-DM and HLA-DR in vivo. Immunity 4:87.
25. Pious, D., L. Dixon, F. Levine, T. Cotner, and R. Johnson. 1985. HLA class II regulation and structure: analysis with HLA-DR3 and HLA-DP point mutants. J. Exp. Med. 162:1193.
26. Pear, W. S., M. L. Scott, and G. P. Nolan. 1997. Generation of high-titer, helper-free retroviruses by transient transfection. In Methods in Molecular Medicine, Gene Therapy Protocols. R. Robbins, ed. Humana Press, Inc., Totowa, NJ, p. 41.
27. Higuchi, R., B. Krummel, and R. K. Saiki. 1988. A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res. 16:7351.
28. Johnson, J. P., T. Meo, G. Riethmüller, D. J. Schendel, and R. Wank. 1982. Direct demonstration of an HLA-DR allotypic determinant on the low molecular weight (beta) subunit using a mouse monoclonal antibody specific for DR3. J. Exp. Med. 156:104.
29. Watanabe, M., T. Suzuki, M. Taniguchi, and N. Shinohara. 1983. Monoclonal anti-Ia murine alloantibodies crossreactive with the Ia-homologues of other mammalian species including humans. Transplantation 36:712.
30. Lampson, L., and R. Levy. 1980. Two populations of Ia-like molecules on a human B cell line. J. Immunol. 125:293.
31. Fu, X. T., and R. W. Karr. 1994. HLA-DRα chain residues located on the outer loops are involved in nonpolymorphic and polymorphic antibody-binding epitopes. Hum. Immunol. 39:253.
32. Avva, R. R., and P. Cresswell. 1994. In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity 1:763.
33. Clark, E. A., and T. Yakoshi. 1984. Human B cell and B cell blast-associated surface molecules defined with monoclonal antibodies. In Leukocyte Typing. A. Bernard, L. Baunsell, J. Sausset, and S. Schlossman, eds. Springer-Verlag, Berlin, p. 339.
34. Johnson, A. H., T. F. Tang, V. Cowell, and C. K. Hurley. 1991. The impact of naturally occurring DR3 microvariants, DRw17 and DRW18, on T-cell allorecognition. Hum. Immunol. 32:46.
35. Mellins, E. D., M. Woelfel, and D. Pious. 1987. Importance of HLA-DQ and -DP restriction elements in T-cell responses to soluble antigens: mutational analysis. Hum. Immunol. 18:211.
36. Avruch, J., and D. F. Wallach. 1971. Preparation and properties of plasma membrane and endoplasmic reticulum fragments from isolated rat fat cells. Biochim. Biophys. Acta 233:334.
37. Horvat, J., J. Baxandall, and O. Touster. 1969. The isolation of lysosomes from Ehrlich ascites tumor cells following pretreatment of mice with Triton WR-1339, J. Cell Biol. 42:469.
38. Hochstenbach, F., V. David, S. Watkins, and M. B. Brenner. 1992. Endoplasmic reticulum resident protein of 90 kilodaltons associates with the T- and B-cell antigen receptors and major histocompatibility complex antigens during their assembly. Proc. Natl. Acad. Sci. USA 89:4734.
39. Chavrier, P., R. G. Parton, H. P. Hauri, K. Simons, and M. Zerial. 1990. Localization of low molecular weight GTP binding proteins to exocytic and endocytic compartments. Cell 62:317.
40. Qiu, Y., X. Xu, A. Wandinger-Ness, D. P. Dalke, and S. K. Pierce. 1994. Separation of subcellular compartments containing distinct functional forms of MHC class II. J. Cell Biol. 125:595.
41. Bucci, C., A. Wandinger-Ness, A. Lutcke, M. Chiariello, C. B. Bruni, and M. Zerial. 1994. Rab 5a is a common component of the apical and basolateral endocytic machinery in polarized epithelial cells. Proc. Natl. Acad. Sci. USA 91:5061.
42. Rask, L., J. B. Lindblom, and P. A. Peterson. 1976. Structural and immunological similarities between HLA antigens from three loci. Eur. J. Immunol. 6:93.
43. Schafer, P. H., J. M. Green, S. Malapati, L. Gu, and S. K. Pierce. 1996. HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes. J. Immunol. 157:5487.
44. Cho, S., M. Attaya, and J. J. Monaco. 1991. New class II-like genes in the murine MHC. Nature 353:573.
45. Shackelford, D. A., and J. L. Strominger. 1983. Analysis of the oligosaccharides on the HLA-DR and DC1 B cell antigens. J. Immunol. 130:274.
46. Blum, J. S., and P. Cresswell. 1988. Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc. Natl. Acad. Sci. USA 85:3975.
47. Nowell, J., and V. Quaranta. 1985. Chloroquine affects biosynthesis of Ia molecules by inhibiting dissociation of invariant (gamma) chains from alpha-beta dimers in B cells. J. Exp. Med. 162:1371.
48. Dayhoff, M. O. 1978. Atlas of Protein Sequence and Structure. National Biomedical Research Foundation, Washington, D.C.
49. Rodan, A. R., J. F. Simons, E. S. Trombetta, and A. Helenius. 1996. N-linked oligosaccharides are necessary and sufficient for association of glycosylated forms of bovine RNase with calnexin and calreticulin. EMBO J. 15:6921.
50. Ora, A., and A. Helenius. 1995. Calnexin fails to associate with substrate proteins in glucosidase-deficient cell lines. J. Biol. Chem. 270:26060.
51. Arunachalam, B., and P. Cresswell. 1995. Molecular requirements for the interaction of class II major histocompatibility complex molecules and invariant chain with calnexin. J. Biol. Chem. 270:2784.
52. Green, J. M., R. DeMars, X. Xu, and S. K. Pierce. 1995. The intracellular transport of MHC class II molecules in the absence of HLA-DM. J. Immunol. 155:3759.
53. Denzin, L. K., N. F. Robbins, C. Carboy-Newcomb, and P. Cresswell. 1994. Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. Immunity 11:595.
54. Lindstedt, R., M. Liljedahl, A. Péléraux, P. A. Peterson, and L. Karlsson. 1995. The MHC class II molecule H2-M is targeted to an endosomal compartment by a tyrosine-based targeting motif. Immunity 3:561.
55. Marks, M. S., P. A. Roche, E. van Donselaar, L. Woodruff, P. J. Peters, and J. S. Bonifacino. 1995. A lysosomal targeting signal in the cytoplasmic tail of the beta chain directs HLA-DM to MHC class II compartments. J. Cell Biol. 131:351.
56. Busch, R., R. C. Doebele, E. von Scheven, J. Fahrni, and E. D. Mellins. 1998. Aberrant intermolecular disulfide bonding in a mutant HLA-DM molecule: implications for assembly, maturation, and function. J. Immunol. 160:734.
57. Liljedahl, M., T. Kuwana, W.-P. Fung-Leung, M. R. Jackson, P. A. Peterson, and L. Karlsson. 1997. HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport. EMBO J. 15:4817.